Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30 participants
OBSERVATIONAL
2025-10-01
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The researchers will look for 90 volunteers for detailed testing. Thirty people who have had a TIA for the first time. For comparisons, the researchers will also include 60 volunteers without TIA (30 treated to prevent TIA and stroke; 30 who do not receive prevention treatments).
Aims and methods:
1. To find out if TIA makes speaking difficult.
People will complete speaking tasks in a quiet place. For example, people will be asked to tell us about their weekend, what they think about climate change.
2. To find out if people are concerned about their speech and other thinking skills after TIA.
People will fill in questionnaires to help us look into these issues.
3. To find out if speaking abilities and people's own views of their communication change over time (about three months after the TIA).
Discovering new knowledge about spoken communication after a TIA diagnosis could change the course of TIA research and care across health professions (speech-language therapy, psychology, audiology, neurology). Future studies could use speaking tasks to scrutinise further the complexity of subtle communication problems after TIA and determine which individuals are likely to have these problems. The project will raise understanding of these issues, enabling affected individuals to seek professional support. Finally, it will also guide development of new TIA recommendations and treatments for these problems thus improving people's quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnosis by Comprehensive Cardiovascular Imaging for Stroke and TIA
NCT03618069
Lleida TIA Intervention Study
NCT04524078
Life After Transient Ischemic Attack
NCT05234528
Study of Admission Versus Discharge After Transient Ischemic Attack (TIA)
NCT00304798
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
NCT01423201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Everyday Memory Questionnaire (Sunderland et al., 1986): Self-reported measure of cognitive skills many of which are about communication, language and reading (Likert scale) (e.g., forgetting the names of friends or relatives or calling them by the wrong names; getting lost or turning in the wrong direction on a journey or walk you have often been on).
Data analyses
For aims 1 and 2, the methods of analysis for each of the outcome measures is detailed below and will be in conducted in R.
Descriptive statistics by subgroup (medians, range, inter-quartile range) will be generated for each outcome measure (speech-related \[primary, secondary\], Everyday Memory Questionnaire, Communication Confidence Rating Scale for Aphasia).
Kruskal-Wallis non-parametric analysis of variance will be carried out for each outcome measure (alpha level .05). Post-hoc pairwise comparisons (using Dunn's test correction for multiple comparisons) for statistically significant results. Effect sizes will also be obtained.
Communication Confidence Rating Scale for Aphasia (Cherney et al., 2011): Self-reported confidence in communication activities (Likert scale) (e.g., how confident are you about your ability to talk with people? How confident are you that people understand you when you talk?)
Connected speech assessment tasks (Whitworth et al., 2015): Assesses connected speech skills, (e.g., can you tell me what you did last weekend? Can you remember a recent celebration such as a birthday, anniversary, wedding or party that you have been to? Can you tell me about it? What do you think about global warming and why?)
For aim 3, descriptive statistics (as above) will be generated for each outcome measure non-parametric Wilcoxon tests (alpha level 0.5) will be used. Effect sizes will also be obtained. These analyses will also be carried out in R.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
English as a secondary language.
Neurological conditions affecting cognitive function (e.g., Parkinson's disease, dementia, stroke).
Self-reported, pre-existing speech or cognitive problems, developmental or acquired.
Demonstrate noticeable difficulties carrying out project-related tasks.
40 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northumbria Healthcare NHS Foundation Trust
OTHER
Newcastle University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christos Salis, PhD
Role: PRINCIPAL_INVESTIGATOR
Newcastle University
Lisa Shaw, MD
Role: STUDY_CHAIR
Newcastle University
Christopher Price, MD
Role: STUDY_CHAIR
Newcastle University
Mahmoud Kargar, MSc
Role: STUDY_CHAIR
Newcastle University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Newcastle University
Newcastle upon Tyne, Tyne and Wear, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TIASPEECHPROTOCOL3132025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.